Currently, metformin is widely utilized as the first-line medical treatment for T2DM individuals, as it ameliorates hyperglycemia, but it is used less commonly in T1DM individuals due to the requirement for insulin supplementation. The gene discussed is INS; the disease is Hyperglycemia.